Display options
Share it on

Front Chem. 2016 Mar 31;4:13. doi: 10.3389/fchem.2016.00013. eCollection 2016.

Effects of Gold Salt Speciation and Structure of Human and Bovine Serum Albumins on the Synthesis and Stability of Gold Nanostructures.

Frontiers in chemistry

Érica G A Miranda, Aryane Tofanello, Adrianne M M Brito, David M Lopes, Lindomar J C Albuquerque, Carlos E de Castro, Fanny N Costa, Fernando C Giacomelli, Fabio F Ferreira, Juliana C Araújo-Chaves, Iseli L Nantes

Affiliations

  1. Centro de Ciências Naturais e Humanas, Universidade Federal do ABC Santo André, Brazil.

PMID: 27066476 PMCID: PMC4814711 DOI: 10.3389/fchem.2016.00013

Abstract

The present study aimed to investigate the influence of albumin structure and gold speciation on the synthesis of gold nanoparticles (GNPs). The strategy of synthesis was the addition of HAuCl4 solutions at different pH values (3-12) to solutions of human and bovine serum albumins (HSA and BSA) at the same corresponding pH values. Different pH values influence the GNP synthesis due to gold speciation. Besides the inherent effect of pH on the native structure of albumins, the use N-ethylmaleimide (NEM)-treated and heat-denaturated forms of HSA and BSA provided additional insights about the influence of protein structure, net charge, and thiol group approachability on the GNP synthesis. NEM treatment, heating, and the extreme values of pH promoted loss of the native albumin structure. The formation of GNPs indicated by the appearance of surface plasmon resonance (SPR) bands became detectable from 15 days of the synthesis processes that were carried out with native, NEM-treated and heat-denaturated forms of HSA and BSA, exclusively at pH 6 and 7. After 2 months of incubation, SPR band was also detected for all synthesis carried out at pH 8.0. The mean values of the hydrodynamic radius (RH) were 24 and 34 nm for GNPs synthesized with native HSA and BSA, respectively. X-ray diffraction (XRD) revealed crystallites of 13 nm. RH, XRD, and zeta potential values were consistent with GNP capping by the albumins. However, the GNPs produced with NEM-treated and heat-denaturated albumins exhibited loss of protein capping by lowering the ionic strength. This result suggests a significant contribution of non-electrostatic interactions of albumins with the GNP surface, in these conditions. The denaturation of proteins exposes hydrophobic groups to the solvent, and these groups could interact with the gold surface. In these conditions, the thiol blockage or oxidation, the latter probably favored upon heating, impaired the formation of a stable capping by thiol coordination with the gold surface. Therefore, the cysteine side chain of albumins is important for the colloidal stabilization of GNPs rather than as the reducing agent for the synthesis. Despite the presence of more reactive gold species at more acidic pH values, i.e., below 6.0, in these conditions the loss of native albumin structure impaired GNP synthesis. Alkaline pH values (9-12) combined the unfavorable conditions of denaturated protein structure with less reactive gold species. Therefore, an optimal condition for the synthesis of GNPs using serum albumins involves more reactive gold salt species combined with a reducing and negatively charged form of the protein, all favored at pH 6-7.

Keywords: bovine serum albumin; gold nanoparticles; gold speciation; human serum albumin; pH; protein structure; reducing and stabilizing agents

References

  1. Analyst. 2010 Jun;135(6):1411-6 - PubMed
  2. Chem Rev. 2014 Aug 13;114(15):7610-30 - PubMed
  3. J Biol Chem. 2000 Feb 4;275(5):3042-50 - PubMed
  4. Metallomics. 2015 Sep;7(9):1364-70 - PubMed
  5. Opt Express. 2012 Jan 2;20(1):621-6 - PubMed
  6. Chem Soc Rev. 2011 Jan;40(1):44-56 - PubMed
  7. Langmuir. 2004 Dec 21;20(26):11594-9 - PubMed
  8. Nanoscale. 2011 May;3(5):2227-32 - PubMed
  9. Biomed Mater. 2008 Sep;3(3):034105 - PubMed
  10. Phys Chem Chem Phys. 2011 Jul 14;13(26):12155-62 - PubMed
  11. PLoS One. 2015 Jul 06;10(7):e0128756 - PubMed
  12. ACS Nano. 2013 Dec 23;7(12):10960-70 - PubMed
  13. Protein Pept Lett. 2004 Aug;11(4):307-15 - PubMed
  14. Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14265-70 - PubMed
  15. IET Nanobiotechnol. 2015 Oct;9(5):314-23 - PubMed
  16. Hepatology. 2005 Jun;41(6):1211-9 - PubMed
  17. J Nanobiotechnology. 2013 Jul 19;11:26 - PubMed
  18. Langmuir. 2008 Jul 15;24(14):7465-73 - PubMed
  19. Phys Chem Chem Phys. 2015 Oct 14;17(38):24866-73 - PubMed
  20. J Phys Chem B. 2006 Nov 23;110(46):23085-91 - PubMed
  21. Int J Nanomedicine. 2015 Aug 26;10:5435-45 - PubMed
  22. Nat Nanotechnol. 2011 Feb;6(2):93-7 - PubMed
  23. Small. 2005 Nov;1(11):1048-52 - PubMed
  24. J Am Chem Soc. 2010 Feb 3;132(4):1296-301 - PubMed
  25. Chem Commun (Camb). 2010 Dec 28;46(48):9209-11 - PubMed
  26. Chem Soc Rev. 2008 Sep;37(9):1783-91 - PubMed
  27. Langmuir. 2010 Mar 16;26(6):4400-8 - PubMed

Publication Types